| Income Statement |
| Total Revenue | 98.27M |
|
| Revenues (USD) | 98.27M |
| Cost of Revenue | 53.86M |
| Gross Profit | 44.41M |
| Operating Expenses | 48.66M |
| Research and Development Expense | 2.49M |
| Selling, General and Administrative Expense | 46.18M |
| Operating Income | -4.25M |
| Interest Expense | 7.81M |
| Income Tax Expense | 32.00K |
| Net Income | -3.23M |
| Net Income Common Stock | -3.23M |
| Net Income Common Stock (USD) | -3.23M |
| Consolidated Income | -3.25M |
| Net Income to Non-Controlling Interests | -16.00K |
| Earnings per Basic Share | -0.74 |
| Earnings per Basic Share (USD) | -0.74 |
| Earnings per Diluted Share | -0.74 |
| Earning Before Interest & Taxes (EBIT) | 4.61M |
| Earning Before Interest & Taxes (USD) | 4.61M |
| Weighted Average Shares | 4.35M |
| Weighted Average Shares Diluted | 4.36M |
| Balance Sheet |
| Cash and Equivalents | 23.30M |
| Cash and Equivalents (USD) | 23.30M |
| Trade and Non-Trade Receivables | 26.23M |
| Current Assets | 114.48M |
| Property, Plant & Equipment Net | 138.19M |
| Total Assets | 264.50M |
| Debt Current | 143.97M |
| Total Debt | 215.18M |
| Current Liabilities | 219.71M |
| Debt Non-Current | 71.21M |
| Total Liabilities | 328.30M |
| Accumulated Retained Earnings (Deficit) | -659.05M |
| Shareholders Equity | -63.77M |
| Shareholders Equity (USD) | -63.77M |
| Assets Non-Current | 150.02M |
| Total Debt (USD) | 215.18M |
| Deferred Revenue | 4.04M |
| Goodwill and Intangible Assets | 5.91M |
| Inventory | 55.40M |
| Liabilities Non-Current | 108.58M |
| Trade and Non-Trade Payables | 41.19M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 4.46M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.65M |
| Capital Expenditure | -2.30M |
| Net Cash Flow from Investing | -2.30M |
| Net Cash Flow from Operations | 647.00K |
| Share Based Compensation | -377.00K |